Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 10365881)

Published in Am J Surg on May 01, 1999

Authors

D M Rose1, W C Chapman, A T Brockenbrough, J K Wright, A T Rose, S Meranze, M Mazer, T Blair, C D Blanke, J P Debelak, C W Pinson

Author Affiliations

1: Department of Radiology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-4753, USA.

Articles citing this

Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma. World J Gastroenterol (2003) 1.11

Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study. World J Gastroenterol (2004) 1.01

Influence of transarterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor and basic fibroblast growth factor in rat with Walker-256 transplanted hepatoma: an experimental study. World J Gastroenterol (2003) 1.00

Ruptured hepatic carcinoma after transcatheter arterial chemoembolization. Curr Ther Res Clin Exp (2013) 0.97

Rupture and intra-peritoneal bleeding of a hepatocellular carcinoma after a transarterial chemoembolization procedure: a case report. Cases J (2009) 0.85

Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization. World J Gastroenterol (2004) 0.85

Comparison of transcatheter arterial chemoembolization, laparoscopic radiofrequency ablation, and conservative treatment for decompensated cirrhotic patients with hepatocellular carcinoma. World J Gastroenterol (2004) 0.84

Predictors of hepatic decompensation after TACE for hepatocellular carcinoma. BMJ Open Gastroenterol (2015) 0.78

Effect of preoperative transcatheter arterial chemoembolization on proliferation of hepatocellular carcinoma cells. World J Gastroenterol (2007) 0.78

Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats. World J Gastroenterol (2004) 0.77

Articles by these authors

Lactose carrier protein of Escherichia coli. Structure and expression of plasmids carrying the Y gene of the lac operon. Eur J Biochem (1980) 3.24

Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol (1999) 2.61

A meta-analysis of selective versus routine nasogastric decompression after elective laparotomy. Ann Surg (1995) 2.58

Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest (1994) 2.33

In vitro and in vivo products of E. coli lactose permease gene are identical. Nature (1980) 2.18

Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. Am J Transplant (2012) 1.88

Improving the outcome in gallstone ileus. Am J Surg (1986) 1.87

The structure of the lactose permease derived from Raman spectroscopy and prediction methods. EMBO J (1985) 1.79

The mechanism of inducer exclusion. Direct interaction between purified III of the phosphoenolpyruvate:sugar phosphotransferase system and the lactose carrier of Escherichia coli. EMBO J (1983) 1.78

Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization. Cancer (1996) 1.69

Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology (1994) 1.64

Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg (1998) 1.63

Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. Ann Oncol (2013) 1.62

Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology (1992) 1.58

Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study. Am J Transplant (2013) 1.54

Anti-peptide antibodies and proteases as structural probes for the lactose/H+ transporter of Escherichia coli: a loop around amino acid residue 130 faces the cytoplasmic side of the membrane. Biochemistry (1986) 1.53

Peptide-specific antibody locates the COOH terminus of the lactose carrier of Escherichia coli on the cytoplasmic side of the plasma membrane. J Biol Chem (1983) 1.51

Acute lung injury after hepatic cryoablation: correlation with NF-kappa B activation and cytokine production. Surgery (1999) 1.50

Comparison of laparoscopic cholecystectomy with open cholecystectomy in a single center. Am J Surg (1993) 1.49

Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Clin Orthop Relat Res (1996) 1.48

Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med (1997) 1.47

Hepatic venous outflow obstruction in pediatric liver transplantation: technical considerations in prevention, diagnosis, and management. Pediatr Transplant (2014) 1.40

Nashville experience with liver transplantation in Veterans Administration patients. J Surg Res (1997) 1.39

A comparison of single photon and dual X-ray absorptiometry of the forearm in children and adults. Bone (1994) 1.38

Sidedness of native membrane vesicles of Escherichia coli and orientation of the reconstituted lactose: H+ carrier. Eur J Biochem (1984) 1.37

Purification of the lactose:H+ carrier of Escherichia coli and characterization of galactoside binding and transport. Eur J Biochem (1984) 1.34

18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg (1999) 1.32

Molecular aspects of sugar:ion cotransport. Annu Rev Biochem (1986) 1.29

Lactose carrier protein of Escherichia coli: interaction with galactosides and protons. Biochemistry (1981) 1.28

Variation in management based on type of choledochal cyst. Am J Surg (1991) 1.24

Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med (1999) 1.19

Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg (1996) 1.19

Image-guided surgery: preliminary feasibility studies of frameless stereotactic liver surgery. Arch Surg (1999) 1.19

General surgical complications after cardiopulmonary bypass surgery. Am J Surg (1983) 1.16

Extended right hepatic lobectomy, left hepatic lobectomy, and skeletonization resection for proximal bile duct cancer. World J Surg (1988) 1.14

A comparison of 399 open and 568 laparoscopic gastric bypasses performed during a 4-year period. Surg Endosc (2007) 1.13

Distinct functions of monoclonal IgG antibody depend on antigen-site specificities. J Exp Med (1979) 1.12

Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer. Ann Oncol (2011) 1.11

Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery (1990) 1.11

Chronic illness in a general practice. Fam Pract (1984) 1.10

Bile duct injury following laparoscopic cholecystectomy: a cause for continued concern. Am Surg (2001) 1.08

Surface registration for use in interactive, image-guided liver surgery. Comput Aided Surg (2000) 1.08

Management of biliary complications after liver transplantation. Am J Surg (1992) 1.08

Isolation of the globular region of the subcomponent q of the C1 component of complement. Hoppe Seylers Z Physiol Chem (1979) 1.08

Southern Memorial Hospital, Melbourne family medical service. Med J Aust (1971) 1.08

The size of the lactose permease derived from rotational diffusion measurements. EMBO J (1985) 1.08

Monoclonal antibodies against human fibroblast collagenase and the design of an enzyme-linked immunosorbent assay to measure total collagenase. Matrix (1992) 1.07

Does the lactose carrier of Escherichia coli function as a monomer? FEBS Lett (1983) 1.07

Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma: results from a phase II study. Cancer (2000) 1.06

Management of bronchobiliary fistula as a late complication of hepatic resection. Am Surg (1998) 1.05

Dysphagia lusoria: aberrant right subclavian artery with a Kommerell's diverticulum. Am Surg (1993) 1.04

Repeat hepatic surgery for colorectal cancer metastasis to the liver. Ann Surg (1996) 1.04

Dimeric, trimeric and tetrameric complexes of immunoglobulin G fix complement. Biochem J (1980) 1.02

Ischemic colitis. An ever-changing spectrum? Am Surg (1991) 1.01

Lactose permease of Escherichia coli: properties of mutants defective in substrate translocation. Proc Natl Acad Sci U S A (1987) 1.00

Technical advances toward interactive image-guided laparoscopic surgery. Surg Endosc (2000) 1.00

Hepatic cryoablation, but not radiofrequency ablation, results in lung inflammation. Ann Surg (2000) 0.99

Radical resection improves survival for patients with pT2 gallbladder carcinoma. Am Surg (2001) 0.97

Embryology, anatomy, and surgical applications of the extrahepatic biliary system. Surg Clin North Am (2000) 0.96

A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices. Ann Oncol (2011) 0.96

Improved islet yields from pancreas preserved in perflurocarbon is via inhibition of apoptosis mediated by mitochondrial pathway. Am J Transplant (2006) 0.96

Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays. J Clin Lab Immunol (1983) 0.95

Surgery in long-term dialysis patients. Experience with more than 300 cases. Am J Surg (1986) 0.93

Antibody-dependent and phytohaemagglutinin-induced lymphocyte cytotoxicity in systemic sclerosis. Clin Exp Immunol (1979) 0.93

Management of fractures with associated arterial injury in combat casualties. J Trauma (1973) 0.92

Lactose permease of Escherichia coli. Methods Enzymol (1983) 0.92

Registration of physical space to laparoscopic image space for use in minimally invasive hepatic surgery. IEEE Trans Med Imaging (2000) 0.92

Localization of the galactoside binding site in the lactose carrier of Escherichia coli. Biochim Biophys Acta (1984) 0.91

An anatomic basis for fetal right ventricular dominance and arterial pressure sensitivity. J Dev Physiol (1987) 0.91

Surgical clips: a cause of late recurrent gallstones. Am Surg (1998) 0.90

Antiperistaltic Roux-en-Y biliary-enteric bypass after bile duct injury: a technical error in reconstruction. Am Surg (1999) 0.90

The incidence of splenectomy is decreasing: lessons learned from trauma experience. Am Surg (2000) 0.90